Sweden vs Zimbabwe: Share of the population living with HIV receiving antiretroviral therapy
Sweden
95.2%
in 2022
Zimbabwe
95.1%
in 2024
Sweden rank
3rd
Zimbabwe rank
4th
Share of the population living with HIV receiving antiretroviral therapy over time
- Sweden
- Zimbabwe
How they compare
Sweden currently reports 95.2% against 95.1% in Zimbabwe, a difference of 0.1%.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was Zimbabwe ahead.
Sweden ranks 3rd and Zimbabwe ranks 4th of 149 countries.
Sweden has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Sweden | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 7.3% | 1.4% | 6.0% | Sweden |
| 2000s | 49.0% | 5.3% | 43.7% | Sweden |
| 2010s | 91.4% | 57.4% | 34.0% | Sweden |
| 2020s | 95.4% | 90.1% | 5.3% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Sweden or Zimbabwe?
- Sweden, at 95.2% against 95.1% in Zimbabwe as of 2022.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Sweden and Zimbabwe?
- 0.1%, with Sweden ahead.
- How many years of comparable data are there for Sweden and Zimbabwe?
- 33 years are reported by both, from 1990 to 2022.
- How do Sweden and Zimbabwe rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Sweden ranks 3rd and Zimbabwe ranks 4th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.